Clozapine (CLZ) is a "gold standard" drug for managing treatment-resistant schizophrenia (TRS), who do not respond adequately to first-line antipsychotics. Despite its efficacy with TRS, the use of ...
The risk for moderate neutropenia associated with clozapine therapy is low in patients with treatment-resistant schizophrenia, and the risk for severe neutropenia is minimal, new research showed. None ...
Antipsychotic (AP) medications are increasingly recognised for their association with a heightened risk of infections. Clozapine, an atypical AP reserved for treatment-resistant schizophrenia (TRS), ...
Clozapine remains the antipsychotic agent of choice for treatment-resistant schizophrenia; however, its efficacy is frequently hampered by adverse effects such as hypersalivation and sialorrhea. These ...
Clozapine 12.5mg, 25mg, 100mg, 150mg, 200mg; contains phenylalanine. Caution with drugs that affect or are affected by CYPA1A2, 2D6, 3A4. Concomitant strong CYP1A2 ...
Three distinct symptoms characterized schizophrenia: positive, negative, and cognitive. Positive symptoms (delusions and hallucinations) improve with typical or atypical antipsychotic medications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results